<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9ACD02BB-EC4C-4346-A6A0-801468590A83"><gtr:id>9ACD02BB-EC4C-4346-A6A0-801468590A83</gtr:id><gtr:name>Tufts University</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/FE1EC3EB-3D38-4ABB-94B2-8429AC475C8F"><gtr:id>FE1EC3EB-3D38-4ABB-94B2-8429AC475C8F</gtr:id><gtr:name>Northwestern University</gtr:name><gtr:address><gtr:line1>633 Clark Street</gtr:line1><gtr:postCode>60208</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/6BE14EEB-8C76-4661-A42D-5BBE8B8AC5ED"><gtr:id>6BE14EEB-8C76-4661-A42D-5BBE8B8AC5ED</gtr:id><gtr:name>Technical University Dresden</gtr:name><gtr:address><gtr:line1>TU Dresden</gtr:line1><gtr:postCode>D-01062</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/02ECE3B0-F864-4593-BCE9-348E204E2058"><gtr:id>02ECE3B0-F864-4593-BCE9-348E204E2058</gtr:id><gtr:name>MRC National Inst for Medical Research</gtr:name><gtr:address><gtr:line1>The Ridgeway</gtr:line1><gtr:line2>Mill Hill</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>NW7 1AA</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/02ECE3B0-F864-4593-BCE9-348E204E2058"><gtr:id>02ECE3B0-F864-4593-BCE9-348E204E2058</gtr:id><gtr:name>MRC National Inst for Medical Research</gtr:name><gtr:address><gtr:line1>The Ridgeway</gtr:line1><gtr:line2>Mill Hill</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>NW7 1AA</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9ACD02BB-EC4C-4346-A6A0-801468590A83"><gtr:id>9ACD02BB-EC4C-4346-A6A0-801468590A83</gtr:id><gtr:name>Tufts University</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/FE1EC3EB-3D38-4ABB-94B2-8429AC475C8F"><gtr:id>FE1EC3EB-3D38-4ABB-94B2-8429AC475C8F</gtr:id><gtr:name>Northwestern University</gtr:name><gtr:address><gtr:line1>633 Clark Street</gtr:line1><gtr:postCode>60208</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/6BE14EEB-8C76-4661-A42D-5BBE8B8AC5ED"><gtr:id>6BE14EEB-8C76-4661-A42D-5BBE8B8AC5ED</gtr:id><gtr:name>Technical University Dresden</gtr:name><gtr:address><gtr:line1>TU Dresden</gtr:line1><gtr:postCode>D-01062</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/280BDE9E-7971-4B68-AC0D-782DD2DC720A"><gtr:id>280BDE9E-7971-4B68-AC0D-782DD2DC720A</gtr:id><gtr:firstName>Jonathan</gtr:firstName><gtr:surname>Stoye</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_U117512710"><gtr:id>3C72F49F-73AD-46C0-A682-6C14F5517C5C</gtr:id><gtr:title>The molecular genetics of mammalian retroviruses and their interaction with their hosts</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_U117512710</gtr:grantReference><gtr:abstractText>A large fraction of the vertebrate genome comprises sequences encoding retroviruses. These elements are called endogenous retroviruses. Since these agents can cause harm it is important that vertebrates can control their own complement of viruses. One strategy to this end is the evolution of so-called restriction factors; natural proteins that can interfere with the replication of retroviruses. Efforts in the lab focus on a better understanding of retrovirus replication and how restriction factors might control the process. We are studying two genes, called Fv1 and Trim5, which are capable of protecting against retroviral infection. We are characterizing their distribution, specificity and mode of action. We hope that this study will give us both a better understanding of how retroviruses grow as well as suggesting alternative means of combating infection by retroviruses like HIV that cause fatal illness in humans.</gtr:abstractText><gtr:technicalSummary>One key step in the retroviral life cycle that takes place in newly infected cells is the integration of newly synthesised retroviral DNA into the cell genome forming a provirus. This allows a permanent association to form between the viral and cellular DNAs; if the infected cell were a germ cell the proviral DNA can become a permanent part of the germ line. The novel provirus, or endogenous retrovirus (ERV), will show stable mendelian inheritance. Current estimates indicate that tens of thousands of these elements are present in the germ line of all vertebrates. Most appear to be silent passengers, but some can be expressed with a variety of consequences for their hosts. Study of the ERVs shows that retroviruses and their hosts have co-existed for tens of millions of years, implying that evolution of natural retrovirus restriction genes is likely. Using a range of molecular and virological techniques we are investigating two such restriction genes. First, we are characterizing a murine gene called Fv1 which acts to interfere with murine leukaemia virus (MLV) replication by preventing integration of viral DNA. Second, we study a primate gene called Trim5 which can prevent reverse transcription of both lentiviruses like HIV and gammaretroviruses like MLV. Fv1 appears to be derived from an endogenous retrovirus. To understand its mode of action, we are carrying out in vitro studies to examine the specificity of restriction, the nature of the interaction between restriction gene and its viral target, interactions with other cellular genes and the importance of the specific intracellular localisation of the Fv1 gene product. Similar studies are also underway with Trim5. One important finding in both systems has been that restriction involves an interaction between a multimeric restriction factor and polymerised viral capsid protein. This emphasizes a need to understand normal retroviral assembly/disassembly thereby prompting us to collaborate extensively with Dr Ian Taylor from the Molecular Structure Division of NIMR. It is hoped that understanding the mode of action of cellular restriction factors will shed light on the early steps in the retroviral life cycle and may ultimately suggest alternative means of interfering with retrovirus replication.</gtr:technicalSummary><gtr:fund><gtr:end>2015-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>1989-07-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>11016958</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC National Institute for Medical Research (NIMR)</gtr:department><gtr:description>ts</gtr:description><gtr:id>8805AC9B-1FF9-4375-B475-A616374A86DE</gtr:id><gtr:impact>16912305 20833376</gtr:impact><gtr:outcomeId>F4F070F1244-1</gtr:outcomeId><gtr:partnerContribution>mathematical modeliing</gtr:partnerContribution><gtr:piContribution>biological/virogical definition of interaction</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Tufts University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>jc</gtr:description><gtr:id>EFF2C532-3DB6-4B6E-85B1-C053B416116E</gtr:id><gtr:impact>17967065 19815721</gtr:impact><gtr:outcomeId>3B92BFF6A07-1</gtr:outcomeId><gtr:partnerContribution>Analysis</gtr:partnerContribution><gtr:piContribution>knowledge</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Technical University of Dresden</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:description>dl</gtr:description><gtr:id>9D9C8126-B543-4223-9574-76F31A45C72D</gtr:id><gtr:impact>18367529</gtr:impact><gtr:outcomeId>C0CBBB33F01-1</gtr:outcomeId><gtr:piContribution>virological analysis</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC National Institute for Medical Research (NIMR)</gtr:department><gtr:description>it</gtr:description><gtr:id>0B2685A3-4824-4613-BEEB-E8FC34C54E65</gtr:id><gtr:impact>16873278 17493656 18222469 19007792 20833376 21483490 21436027</gtr:impact><gtr:outcomeId>3F602DE4975-1</gtr:outcomeId><gtr:partnerContribution>Expertise protein biochemistry/structure determination</gtr:partnerContribution><gtr:piContribution>Biological/virological characterization of proteins</gtr:piContribution><gtr:sector>Public</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC National Institute for Medical Research (NIMR)</gtr:department><gtr:description>aog</gtr:description><gtr:id>1E828FF8-B35D-414A-B940-69050CD54541</gtr:id><gtr:impact>18286572 18714015 21131187</gtr:impact><gtr:outcomeId>43C7376D6D6-1</gtr:outcomeId><gtr:partnerContribution>experimental/analysis</gtr:partnerContribution><gtr:piContribution>knowledge</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Northwestern University Chicago</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>th</gtr:description><gtr:id>BAE4CE66-291D-4B80-BF23-11A3E50DB3BB</gtr:id><gtr:impact>17392513</gtr:impact><gtr:outcomeId>4A515E96EAA-1</gtr:outcomeId><gtr:partnerContribution>analysis, discussion</gtr:partnerContribution><gtr:piContribution>Microscopical analysis</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>acre</gtr:description><gtr:geographicReach>UK</gtr:geographicReach><gtr:id>5C8B8B13-6DD8-427E-B4DE-37BBCE786956</gtr:id><gtr:impact>Membership of ACRE (2002-2008) Advice to UK Gov on GM releases into environment</gtr:impact><gtr:outcomeId>PBZ9FXUwpSp</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>vectors</gtr:description><gtr:geographicReach>UK</gtr:geographicReach><gtr:id>6C3031A3-41BA-4ABA-877A-F1A52D4A1FFA</gtr:id><gtr:impact>ad hoc advisor to SACGM on most appropriate classification of activities involving retroviral/lentiviral vectors. Revised guidelines issued.</gtr:impact><gtr:outcomeId>nZATJ6cb31B</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>xmrv</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>3C57E2CF-2374-4068-91D7-EC6811B9AE68</gtr:id><gtr:impact>advised UK-DOH nepnei, USA FDA bpac, Canadian PHA on risk of XMRV to blood supply</gtr:impact><gtr:outcomeId>CNh3X5qrSCX</gtr:outcomeId><gtr:type>Gave evidence to a government review</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>48BB5296-E8FF-4655-AA39-E6082FAF4830</gtr:id><gtr:title>Virology. A new virus for old diseases?</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2d41938a4425d6ee7b1af0d1455a70b1"><gtr:id>2d41938a4425d6ee7b1af0d1455a70b1</gtr:id><gtr:otherNames>Coffin JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn><gtr:outcomeId>88C0B65173A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>60CF8F7B-2C6E-477A-A398-6A995D900255</gtr:id><gtr:title>Type I interferon-dependent and -independent expression of tripartite motif proteins in immune cells.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a816de6a63c6a3a5f15aba6f35974a35"><gtr:id>a816de6a63c6a3a5f15aba6f35974a35</gtr:id><gtr:otherNames>Rajsbaum R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn><gtr:outcomeId>9CDFE2B3A64</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F21733FC-071E-4432-9516-B33A22C3B4E0</gtr:id><gtr:title>Binding of more than one Tva800 molecule is required for ASLV-A entry.</gtr:title><gtr:parentPublicationTitle>Retrovirology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f0788e79a32e1e1b065a44e20d7ea9c5"><gtr:id>f0788e79a32e1e1b065a44e20d7ea9c5</gtr:id><gtr:otherNames>Gray ER</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1742-4690</gtr:issn><gtr:outcomeId>FRneW4Fdjau</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>02CEE250-237C-4238-93D3-6DCAD996CCD5</gtr:id><gtr:title>A single amino acid change in the SPRY domain of human Trim5alpha leads to HIV-1 restriction.</gtr:title><gtr:parentPublicationTitle>Current biology : CB</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/117c82c2083da818b7e373108a8d6ad1"><gtr:id>117c82c2083da818b7e373108a8d6ad1</gtr:id><gtr:otherNames>Yap MW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0960-9822</gtr:issn><gtr:outcomeId>0B7B8F729FB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9F323535-85C3-4D30-8A10-A95892758EAE</gtr:id><gtr:title>Evolution of the retroviral restriction gene Fv1: inhibition of non-MLV retroviruses.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/117c82c2083da818b7e373108a8d6ad1"><gtr:id>117c82c2083da818b7e373108a8d6ad1</gtr:id><gtr:otherNames>Yap MW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>54563a0e450027.34318866</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>98ED53BC-51C9-49BE-8B24-54A42E7ACDA4</gtr:id><gtr:title>TRIM family proteins: retroviral restriction and antiviral defence.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/21c2e7b6a4b98b466a240fafda9bb697"><gtr:id>21c2e7b6a4b98b466a240fafda9bb697</gtr:id><gtr:otherNames>Nisole S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>1740-1526</gtr:issn><gtr:outcomeId>547FA1C9375</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>19E6E683-69EF-41FB-A904-B6B2FBD25D53</gtr:id><gtr:title>Koala retrovirus: a genome invasion in real time.</gtr:title><gtr:parentPublicationTitle>Genome biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/52edf2f7f43b53b0192bcb0fad417b27"><gtr:id>52edf2f7f43b53b0192bcb0fad417b27</gtr:id><gtr:otherNames>Stoye JP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1474-7596</gtr:issn><gtr:outcomeId>9B2BEEE36BD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BAD2DA37-4479-4010-9FF9-0FE8B0ED31D1</gtr:id><gtr:title>Emv2, the only endogenous ecotropic murine leukemia virus of C57BL/6J mice.</gtr:title><gtr:parentPublicationTitle>Retrovirology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/49e472fa340329ea5fe7ab0f0d3df364"><gtr:id>49e472fa340329ea5fe7ab0f0d3df364</gtr:id><gtr:otherNames>Young GR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1742-4690</gtr:issn><gtr:outcomeId>pm_13745_25_22439680</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B4B04516-A586-40D4-9A50-0CFF66BF38EB</gtr:id><gtr:title>Susceptibility of xenotropic murine leukemia virus-related virus (XMRV) to retroviral restriction factors.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1967f1ef6807f4bedadc0b6799a69e9a"><gtr:id>1967f1ef6807f4bedadc0b6799a69e9a</gtr:id><gtr:otherNames>Groom HC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>cecbNEq7QKD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BE6EEFCC-CD46-4259-833E-6965114F21A1</gtr:id><gtr:title>Negative selection by an endogenous retrovirus promotes a higher-avidity CD4+ T cell response to retroviral infection.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/49e472fa340329ea5fe7ab0f0d3df364"><gtr:id>49e472fa340329ea5fe7ab0f0d3df364</gtr:id><gtr:otherNames>Young GR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>pm_13745_25_22589728</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FB3D21A5-0C8D-46B9-AFBB-BFD717AEA315</gtr:id><gtr:title>Absence of xenotropic murine leukaemia virus-related virus in UK patients with chronic fatigue syndrome.</gtr:title><gtr:parentPublicationTitle>Retrovirology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1967f1ef6807f4bedadc0b6799a69e9a"><gtr:id>1967f1ef6807f4bedadc0b6799a69e9a</gtr:id><gtr:otherNames>Groom HC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1742-4690</gtr:issn><gtr:outcomeId>F72245C0A77</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B42276D8-0A4C-48B2-94C4-1D64D86B2674</gtr:id><gtr:title>Tripartite-motif proteins and innate immune regulation.</gtr:title><gtr:parentPublicationTitle>Current opinion in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a567e445f45cd9579c85c397f97b850e"><gtr:id>a567e445f45cd9579c85c397f97b850e</gtr:id><gtr:otherNames>McNab FW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0952-7915</gtr:issn><gtr:outcomeId>haJygXGWdMk</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>598887FC-FDB1-498E-A63F-25126E5BA899</gtr:id><gtr:title>Phospho-dependent Regulation of SAMHD1 Oligomerisation Couples Catalysis and Restriction.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9a7774931da296e9244084fe229ea4b0"><gtr:id>9a7774931da296e9244084fe229ea4b0</gtr:id><gtr:otherNames>Arnold LH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>56b0e72880d5b5.80989764</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F369F252-BE4C-4D70-A34A-5C182520DFD0</gtr:id><gtr:title>Structural basis of lentiviral subversion of a cellular protein degradation pathway.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b0e91978b81c011b0d7d6bb8b4f367c1"><gtr:id>b0e91978b81c011b0d7d6bb8b4f367c1</gtr:id><gtr:otherNames>Schwefel D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>pm_540e182e182429466</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>949AECC6-A33E-41E9-83DA-CE84D96CB712</gtr:id><gtr:title>HIV-1 restriction factor SAMHD1 is a deoxynucleoside triphosphate triphosphohydrolase.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/567b9a23790faae26ebd0267ac4ec854"><gtr:id>567b9a23790faae26ebd0267ac4ec854</gtr:id><gtr:otherNames>Goldstone DC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>qdWFMZaQCtj</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5998CE6F-4E30-48EF-AF48-62A04FEE204C</gtr:id><gtr:title>Restriction of foamy viruses by primate Trim5alpha.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/117c82c2083da818b7e373108a8d6ad1"><gtr:id>117c82c2083da818b7e373108a8d6ad1</gtr:id><gtr:otherNames>Yap MW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>0B46D3C91AE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C1815C00-AC2B-4D3D-ACB0-F7A377F785B3</gtr:id><gtr:title>Capsid-binding retrovirus restriction factors: discovery, restriction specificity and implications for the development of novel therapeutics.</gtr:title><gtr:parentPublicationTitle>The Journal of general virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/026fb63513df2ff4972c4d7fa6d8cb52"><gtr:id>026fb63513df2ff4972c4d7fa6d8cb52</gtr:id><gtr:otherNames>Sanz-Ramos M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-1317</gtr:issn><gtr:outcomeId>pm_13745_25_24026671</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0390ECFA-0A21-42E1-A839-DF447FBAC85C</gtr:id><gtr:title>A comparison of murine leukemia viruses that escape from human and rhesus macaque TRIM5as.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9502bcccc662911703ba7b285fdc545f"><gtr:id>9502bcccc662911703ba7b285fdc545f</gtr:id><gtr:otherNames>Ohkura S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>pm_13745_25_23536686</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D1C56508-C5EC-4C13-AF9C-F165D76FDE76</gtr:id><gtr:title>Mammalian Endogenous Retroviruses.</gtr:title><gtr:parentPublicationTitle>Microbiology spectrum</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cb2d37bd508a0795cbff6b24386f7dbd"><gtr:id>cb2d37bd508a0795cbff6b24386f7dbd</gtr:id><gtr:otherNames>Mager DL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2165-0497</gtr:issn><gtr:outcomeId>56b0e728578586.71710712</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>78861C60-4E44-43B3-9339-FC987A584138</gtr:id><gtr:title>Structure of B-MLV capsid amino-terminal domain reveals key features of viral tropism, gag assembly and core formation.</gtr:title><gtr:parentPublicationTitle>Journal of molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/505ff33fa1083d5f5b706fe4db0f6e1d"><gtr:id>505ff33fa1083d5f5b706fe4db0f6e1d</gtr:id><gtr:otherNames>Mortuza GB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-2836</gtr:issn><gtr:outcomeId>A558E208D19</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CE5F3DA8-29B9-4D11-914B-CDB78D906473</gtr:id><gtr:title>Capsid processing requirements for abrogation of Fv1 and Ref1 restriction.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/83b6281cefb681374e479cf982ff5553"><gtr:id>83b6281cefb681374e479cf982ff5553</gtr:id><gtr:otherNames>Dodding MP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>B1EE261B25E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>21766898-CC34-43D9-A02A-184CECD0CA38</gtr:id><gtr:title>Resurrection of endogenous retroviruses in antibody-deficient mice.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/49e472fa340329ea5fe7ab0f0d3df364"><gtr:id>49e472fa340329ea5fe7ab0f0d3df364</gtr:id><gtr:otherNames>Young GR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>pm_13745_25_23103862</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B52EEB03-64F1-496C-9400-79E34F6A7DC7</gtr:id><gtr:title>Molecular determinants for recognition of divergent SAMHD1 proteins by the lentiviral accessory protein Vpx.</gtr:title><gtr:parentPublicationTitle>Cell host &amp; microbe</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b0e91978b81c011b0d7d6bb8b4f367c1"><gtr:id>b0e91978b81c011b0d7d6bb8b4f367c1</gtr:id><gtr:otherNames>Schwefel D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1931-3128</gtr:issn><gtr:outcomeId>56b0e72820f5b1.41112223</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2C618381-110C-4ACE-B620-632AC64DCEA1</gtr:id><gtr:title>PCR master mixes harbour murine DNA sequences. Caveat emptor!</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d8bf6155434bcf5024f82bd4c20489ca"><gtr:id>d8bf6155434bcf5024f82bd4c20489ca</gtr:id><gtr:otherNames>Tuke PW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>ACA497DA_FACA497DA_F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DF939D1C-49D1-4E4F-BFA7-B7EE33442E69</gtr:id><gtr:title>Characterization of an amino-terminal dimerization domain from retroviral restriction factor Fv1.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0f34fd810c25c8c8a184709b013beb0e"><gtr:id>0f34fd810c25c8c8a184709b013beb0e</gtr:id><gtr:otherNames>Bishop KN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>E099E73E2A6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>21BAABF1-CC94-49FD-9FA2-8A3F7236EE36</gtr:id><gtr:title>Apparent effect of rabbit endogenous lentivirus type K acquisition on retrovirus restriction by lagomorph Trim5as.</gtr:title><gtr:parentPublicationTitle>Philosophical transactions of the Royal Society of London. Series B, Biological sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/117c82c2083da818b7e373108a8d6ad1"><gtr:id>117c82c2083da818b7e373108a8d6ad1</gtr:id><gtr:otherNames>Yap MW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0962-8436</gtr:issn><gtr:outcomeId>pm_13745_25_23938750</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>406E801F-7F44-4468-806E-8EE37A1DED44</gtr:id><gtr:title>Unique spectrum of activity of prosimian TRIM5alpha against exogenous and endogenous retroviruses.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e0e338dac7248e48ed857c489e453383"><gtr:id>e0e338dac7248e48ed857c489e453383</gtr:id><gtr:otherNames>Rahm N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>ZHyThSkTDKb</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>40F85505-1546-4386-9561-712A6B79FEF6</gtr:id><gtr:title>Structure of the capsid amino-terminal domain from the betaretrovirus, Jaagsiekte sheep retrovirus.</gtr:title><gtr:parentPublicationTitle>Journal of molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/505ff33fa1083d5f5b706fe4db0f6e1d"><gtr:id>505ff33fa1083d5f5b706fe4db0f6e1d</gtr:id><gtr:otherNames>Mortuza GB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-2836</gtr:issn><gtr:outcomeId>58561990276</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4E4A41A0-64B8-4773-B044-F1F3F46C1B99</gtr:id><gtr:title>TRIM5 alpha cytoplasmic bodies are highly dynamic structures.</gtr:title><gtr:parentPublicationTitle>Molecular biology of the cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fea1d443be28d2ed4910ca829c5e48af"><gtr:id>fea1d443be28d2ed4910ca829c5e48af</gtr:id><gtr:otherNames>Campbell EM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1059-1524</gtr:issn><gtr:outcomeId>9D7FA6C247C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DEFF8B39-C9AF-4076-8D6D-C03E374AD015</gtr:id><gtr:title>Virology. Our viral inheritance.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9534aa604573ebb664d3a86545b1f41b"><gtr:id>9534aa604573ebb664d3a86545b1f41b</gtr:id><gtr:otherNames>Weiss RA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn><gtr:outcomeId>pm_13745_25_23687035</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>09F90FDF-703C-4C18-B3D5-F1EBC39ACAF2</gtr:id><gtr:title>A unique spumavirus Gag N-terminal domain with functional properties of orthoretroviral matrix and capsid.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/567b9a23790faae26ebd0267ac4ec854"><gtr:id>567b9a23790faae26ebd0267ac4ec854</gtr:id><gtr:otherNames>Goldstone DC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>pm_13745_25_23675305</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A841AAAE-59AB-4B31-9220-E22CC9F15A45</gtr:id><gtr:title>Ordered assembly of murine leukemia virus capsid protein on lipid nanotubes directs specific binding by the restriction factor, Fv1.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7d849bcff7512ae0e8f595615237a927"><gtr:id>7d849bcff7512ae0e8f595615237a927</gtr:id><gtr:otherNames>Hilditch L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>XWLWz9aERC7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>28FAB2A3-1BDA-4023-BB0B-C76D44182D2A</gtr:id><gtr:title>All three variable regions of the TRIM5alpha B30.2 domain can contribute to the specificity of retrovirus restriction.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9502bcccc662911703ba7b285fdc545f"><gtr:id>9502bcccc662911703ba7b285fdc545f</gtr:id><gtr:otherNames>Ohkura S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>4FCB8B520A9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F6398508-4482-40BD-A683-58A749BCE1CF</gtr:id><gtr:title>Proviral protein provides placental function.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/52edf2f7f43b53b0192bcb0fad417b27"><gtr:id>52edf2f7f43b53b0192bcb0fad417b27</gtr:id><gtr:otherNames>Stoye JP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>9F2670BD5A8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>28D83D7B-01F8-4285-ABC7-B633972AB0BE</gtr:id><gtr:title>Role of APOBEC3 in genetic diversity among endogenous murine leukemia viruses.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/24689ddf3ee782d2caded1dd4773883d"><gtr:id>24689ddf3ee782d2caded1dd4773883d</gtr:id><gtr:otherNames>Jern P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn><gtr:outcomeId>590ED40A23C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C4806BEE-858D-492C-B409-C3C21F346171</gtr:id><gtr:title>Studies of endogenous retroviruses reveal a continuing evolutionary saga.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/52edf2f7f43b53b0192bcb0fad417b27"><gtr:id>52edf2f7f43b53b0192bcb0fad417b27</gtr:id><gtr:otherNames>Stoye JP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1740-1526</gtr:issn><gtr:outcomeId>pm_13745_25_22565131</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>23F59C67-7429-49C4-AE40-A2E04F26B406</gtr:id><gtr:title>Are human endogenous retroviruses pathogenic? An approach to testing the hypothesis.</gtr:title><gtr:parentPublicationTitle>BioEssays : news and reviews in molecular, cellular and developmental biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/49e472fa340329ea5fe7ab0f0d3df364"><gtr:id>49e472fa340329ea5fe7ab0f0d3df364</gtr:id><gtr:otherNames>Young GR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0265-9247</gtr:issn><gtr:outcomeId>pm_13745_25_23864388</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4260C959-AE98-4896-9460-23D41539E07C</gtr:id><gtr:title>Structural and functional analysis of prehistoric lentiviruses uncovers an ancient molecular interface.</gtr:title><gtr:parentPublicationTitle>Cell host &amp; microbe</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/567b9a23790faae26ebd0267ac4ec854"><gtr:id>567b9a23790faae26ebd0267ac4ec854</gtr:id><gtr:otherNames>Goldstone DC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1931-3128</gtr:issn><gtr:outcomeId>rppCGK8rqW4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C35D74AA-AD48-4DE5-AA0B-4BD064B3D45A</gtr:id><gtr:title>Structural studies of postentry restriction factors reveal antiparallel dimers that enable avid binding to the HIV-1 capsid lattice.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/567b9a23790faae26ebd0267ac4ec854"><gtr:id>567b9a23790faae26ebd0267ac4ec854</gtr:id><gtr:otherNames>Goldstone DC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>54563a0e6d1471.98613392</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>322E1F6F-B9C7-4D04-885B-44085C07107B</gtr:id><gtr:title>Trim-cyclophilin A fusion proteins can restrict human immunodeficiency virus type 1 infection at two distinct phases in the viral life cycle.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/117c82c2083da818b7e373108a8d6ad1"><gtr:id>117c82c2083da818b7e373108a8d6ad1</gtr:id><gtr:otherNames>Yap MW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>62EF57D15B6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1FFA75A3-0D8A-404C-A059-2057FA0B3F78</gtr:id><gtr:title>The xenotropic murine leukemia virus-related retrovirus debate continues at first international workshop.</gtr:title><gtr:parentPublicationTitle>Retrovirology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/52edf2f7f43b53b0192bcb0fad417b27"><gtr:id>52edf2f7f43b53b0192bcb0fad417b27</gtr:id><gtr:otherNames>Stoye JP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1742-4690</gtr:issn><gtr:outcomeId>Q7MQNGwV5ZT</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>186BCA34-EA96-44DC-B098-AD068B8BBAA3</gtr:id><gtr:title>B lymphocyte activation by coinfection prevents immune control of friend virus infection.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/266709da30c6d35403936371e559db48"><gtr:id>266709da30c6d35403936371e559db48</gtr:id><gtr:otherNames>Marques R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>F1FFE861583</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>81CFB909-C768-4818-B1DD-16FF33110F6B</gtr:id><gtr:title>Chance favors a prepared genome.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/52edf2f7f43b53b0192bcb0fad417b27"><gtr:id>52edf2f7f43b53b0192bcb0fad417b27</gtr:id><gtr:otherNames>Stoye JP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>D066702C454</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7906840A-2794-4F59-80F9-EE5E88334464</gtr:id><gtr:title>Novel escape mutants suggest an extensive TRIM5a binding site spanning the entire outer surface of the murine leukemia virus capsid protein.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9502bcccc662911703ba7b285fdc545f"><gtr:id>9502bcccc662911703ba7b285fdc545f</gtr:id><gtr:otherNames>Ohkura S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>jJA9QP52sFS</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AC4C4E0C-E8C0-428C-BDB4-F86C0F408F01</gtr:id><gtr:title>The design of artificial retroviral restriction factors.</gtr:title><gtr:parentPublicationTitle>Virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/117c82c2083da818b7e373108a8d6ad1"><gtr:id>117c82c2083da818b7e373108a8d6ad1</gtr:id><gtr:otherNames>Yap MW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0042-6822</gtr:issn><gtr:outcomeId>AB597D050EA</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_U117512710</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>7C58A707-1BF6-4573-A44F-30B271C80813</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Cancer</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>